|Mr. Earnest Blackmon||Chairman, Pres & CEO||308.83k||N/A||1972|
|Mr. John Walsh||Treasurer & Chief Financial Officer||270.83k||N/A||1947|
|Mr. Chadwick Ruby||COO, Sec. & Director||302.1k||N/A||1976|
|Dr. Gregory Gerdeman||Chief Scientific Officer||N/A||N/A||N/A|
|Mr. Jesús Mijares Vázquez||VP & Gen. Counsel||N/A||N/A||N/A|
United Cannabis Corporation owns intellectual properties related to growth, production, manufacture, marketing, management, utilization, and distribution of medical and recreational marijuana, and marijuana infused products in the United States and the Cayman Islands. The company focuses on developing therapeutics, including Prana Bio Nutrient Medicinal products for supplement deficiencies related to the endocannabinoid system, including pain, neuropathy, arthritis, MS, IBS, autism, seizures, eczema, sleep, anxiety, head trauma, opioid dependency, and clinical endocannabinoid deficiencies; and Prana Aromatherapy Transdermal Roll-on line that provides targeted and large surface relief with combinations of aromatherapy. It also develops Epidiferphane, a therapeutic for the prevention of the negative side effects of chemotherapy, as well as therapeutics for the management of rheumatoid arthritis and treatment of brain cancer. The company was formerly known as MySkin, Inc. and changed its name to United Cannabis Corporation in May 2014. United Cannabis Corporation was founded in 2007 and is based in Golden, Colorado. On April 20, 2020, United Cannabis Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Colorado. It is in joint administration with UC Colorado Corporation.
United Cannabis Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.